Bank of New York Mellon’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Sell
19,510
-1,048,130
-98% -$17.3M ﹤0.01% 3973
2026
Q1
$17.4M Buy
1,067,640
+5,356
+0.5% +$83.8K ﹤0.01% 1615
2025
Q4
$15.8M Sell
1,062,284
-195,737
-16% -$2.77M ﹤0.01% 1671
2025
Q3
$16.2M Sell
1,258,021
-52,015
-4% -$693K ﹤0.01% 1659
2025
Q2
$19.9M Sell
1,310,036
-33,732
-3% -$526K ﹤0.01% 1524
2025
Q1
$22.4M Sell
1,343,768
-40,792
-3% -$751K ﹤0.01% 1433
2024
Q4
$26.1M Sell
1,384,560
-1,389,785
-50% -$26.8M ﹤0.01% 1407
2024
Q3
$52.1M Sell
2,774,345
-333,611
-11% -$6.39M 0.01% 1003
2024
Q2
$58.7M Sell
3,107,956
-340,076
-10% -$5.8M 0.01% 931
2024
Q1
$56M Sell
3,448,032
-90,647
-3% -$1.33M 0.01% 966
2023
Q4
$44.8M Sell
3,538,679
-131,732
-4% -$1.66M 0.01% 1111
2023
Q3
$50M Sell
3,670,411
-71,892
-2% -$1.11M 0.01% 980
2023
Q2
$64.2M Sell
3,742,303
-151,498
-4% -$2.35M 0.01% 866
2023
Q1
$54.2M Sell
3,893,801
-12,153
-0.3% -$179K 0.01% 963
2022
Q4
$52.3M Sell
3,905,954
-49,260
-1% -$637K 0.01% 959
2022
Q3
$47.1M Buy
3,955,214
+1,255,755
+47% +$17.8M 0.01% 999
2022
Q2
$34.4M Sell
2,699,459
-45,253
-2% -$581K 0.01% 1210
2022
Q1
$35.5M Buy
2,744,712
+20,845
+0.8% +$275K 0.01% 1320
2021
Q4
$43.1M Buy
2,723,867
+544,836
+25% +$9.3M 0.01% 1263
2021
Q3
$42.5M Sell
2,179,031
-74,016
-3% -$1.47M 0.01% 1242
2021
Q2
$51.3M Sell
2,253,047
-12,864
-0.6% -$267K 0.01% 1121
2021
Q1
$41.6M Buy
2,265,911
+60,172
+3% +$987K 0.01% 1231
2020
Q4
$32.9M Buy
2,205,739
+3,159
+0.1% +$41.2K 0.01% 1316
2020
Q3
$24.7M Sell
2,202,580
-106,080
-5% -$1.04M 0.01% 1340
2020
Q2
$18.3M Sell
2,308,660
-45,154
-2% -$374K ﹤0.01% 1496
2020
Q1
$19M Sell
2,353,814
-194,272
-8% -$2.31M 0.01% 1317
2019
Q4
$32M Buy
2,548,086
+14,672
+0.6% +$158K 0.01% 1263
2019
Q3
$22.6M Sell
2,533,414
-49,700
-2% -$434K 0.01% 1455
2019
Q2
$22.1M Buy
2,583,114
+76,926
+3% +$608K 0.01% 1514
2019
Q1
$19M Sell
2,506,188
-88,804
-3% -$714K 0.01% 1569
2018
Q4
$21.5M Buy
2,594,992
+65,648
+3% +$628K 0.01% 1431
2018
Q3
$25.1M Buy
2,529,344
+186,539
+8% +$1.93M 0.01% 1469
2018
Q2
$22.9M Sell
2,342,805
-17,582
-0.7% -$173K 0.01% 1520
2018
Q1
$21.9M Buy
2,360,387
+25,159
+1% +$240K 0.01% 1514
2017
Q4
$22.2M Sell
2,335,228
-175,068
-7% -$1.67M 0.01% 1497
2017
Q3
$26M Sell
2,510,296
-144,461
-5% -$1.33M 0.01% 1408
2017
Q2
$22M Sell
2,654,757
-145,941
-5% -$1.1M 0.01% 1494
2017
Q1
$20.1M Buy
2,800,698
+222,989
+9% +$1.62M 0.01% 1547
2016
Q4
$18.4M Buy
2,577,709
+232,471
+10% +$1.62M 0.01% 1585
2016
Q3
$17.1M Buy
2,345,238
+23,746
+1% +$151K 0.01% 1548
2016
Q2
$13.6M Sell
2,321,492
-116,928
-5% -$775K ﹤0.01% 1665
2016
Q1
$15.5M Buy
2,438,420
+38,371
+2% +$206K ﹤0.01% 1580
2015
Q4
$15.4M Buy
2,400,049
+20,650
+0.9% +$129K ﹤0.01% 1570
2015
Q3
$13.8M Sell
2,379,399
-77,143
-3% -$572K ﹤0.01% 1667
2015
Q2
$21.4M Sell
2,456,542
-1,665,413
-40% -$14M 0.01% 1442
2015
Q1
$32.9M Sell
4,121,955
-1,118,017
-21% -$8.35M 0.01% 1141
2014
Q4
$40.7M Sell
5,239,972
-93,890
-2% -$685K 0.01% 1012
2014
Q3
$34.6M Sell
5,333,862
-125,794
-2% -$972K 0.01% 1088
2014
Q2
$45.9M Buy
5,459,656
+1,134,992
+26% +$8.8M 0.01% 958
2014
Q1
$29M Buy
4,324,664
+1,616,916
+60% +$9.8M 0.01% 1233
2013
Q4
$16.9M Buy
2,707,748
+1,537,414
+131% +$7.51M ﹤0.01% 1574
2013
Q3
$5.09M Sell
1,170,334
-211,705
-15% -$968K ﹤0.01% 2235
2013
Q2
$6.11M Buy
+1,382,039
New +$6.12M ﹤0.01% 2066

Other funds holding SEM

Bank of New York Mellon's SEM Position: Q2 2026 in Review

Bank of New York Mellon reduced its Select Medical (SEM) stake by 98% in Q2 2026, selling an estimated $17.3M and leaving 19,510 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

Bank of New York Mellon first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $64.2M in Q2 2023. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Bank of New York Mellon held 19,510 shares of Select Medical worth $322K as of Q2 2026.
  • Bank of New York Mellon sold 1,048,130 Select Medical shares in Q2 2026, an estimated $17.3M.
  • Select Medical made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3973 holding.
  • Bank of New York Mellon first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Select Medical position peaked at $64.2M in Q2 2023.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.